Value Added to Portfolio Companies
Access to Cornell
Portfolio companies have access to the resources of Cornell across leading departments in engineering, technology, and medicine. In addition, portfolio companies can capitalize on Cornell’s network of globally renowned subject matter experts.
With a team of full-time MBA students, BR Venture Fund provides portfolio companies with a vast amount of business expertise from management consultants, investment bankers, venture capitalists, doctors, lawyers and more.
BR Venture Fund operates out of Cornell’s main campus in Ithaca and Cornell Tech in New York City. Cornell Tech connects our portfolio companies to a growing network of computer scientists, data scientists, tech-focused MBAs, and hardware gurus.
LOOKING FOR FUNDING?
BRV invests in U.S.-based early-stage companies across all industries.
Big Red Ventures Makes First Investment of 2022-23 in ATDev
Big Red Ventures (BRV), Cornell’s early-stage venture capital fund, is excited to announce its investment in Assistive Technology Development, Inc. (ATDev), a medical device company focused on mobility, marking BRV’s first investment of 2022-23. “ATDev is...
An Interview with Sarah Fox, Associate at Windham Venture Partners
Sarah Fox is a Senior Associate at Windham Venture Partners, a venture fund investing in healthcare technology companies. Ms. Fox regularly sources deals, assesses opportunities, and supports portfolio companies. Her time at Windham follows time studying at Cornell...
An Interview with Sushant Shenoy, Principal with the Dubai Future District Fund
Sushant is a Principal with the Dubai Future District Fund (DFDF), the evergreen venture capital fund of funds of Dubai, anchored by the Dubai International Finance Centre (DIFC) and the Dubai Future Foundation (DFF). Sushant received his BS from Indiana University’s...
An interview with Dr. Kneeland Youngblood, Founding Partner, Chairman, and CEO at Pharos Capital Group.
An interview with Kneeland Youngblood MD, Founding Partner, Chairman, and CEO at Pharos Capital Group. Dr. Youngblood is an accomplished physician, board director, statesman, and private equity investor. In this interview with Ikenna Nwafor, Dr. Youngblood discusses...